Newly Formed Abivax Of France Links With Cuba To Develop Vaccines
This article was originally published in The Pink Sheet Daily
Executive Summary
New French biotech Abivax is tapping into Cuba’s vaccine expertise in hopes of becoming a leader in the field, initially targeting Asia with its lead Hepatitis B jab, which it says offers the potential to cure the disease.